| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |